Solar cheilosis: an ominous precursor part II. Therapeutic perspectives

J Am Acad Dermatol. 2012 Feb;66(2):187-98; quiz 199-200. doi: 10.1016/j.jaad.2011.09.039.

Abstract

The differential diagnosis of SC includes malignant, premalignant, metastatic, inflammatory, and eczematoid disorders, along with photodermatoses and a few rare but important disorders of the lower lip. Current treatment options include topical, ablative, and surgical therapies. Several clinical challenges are also addressed, including the issue of obtaining a high-yield diagnostic biopsy specimen while minimizing patient morbidity, field-directed treatment for SC, and strategies for combination therapy.

MeSH terms

  • Administration, Topical
  • Aminoquinolines / administration & dosage
  • Aminoquinolines / therapeutic use
  • Biopsy
  • Carcinoma, Squamous Cell / therapy*
  • Cheilitis / pathology
  • Cheilitis / surgery
  • Cheilitis / therapy*
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Diclofenac / administration & dosage
  • Diclofenac / therapeutic use
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / therapeutic use
  • Humans
  • Imiquimod
  • Lip Neoplasms / therapy*
  • Male
  • Middle Aged
  • Precancerous Conditions / therapy
  • Skin Neoplasms / therapy*
  • Sunlight / adverse effects

Substances

  • Aminoquinolines
  • Diclofenac
  • Imiquimod
  • Fluorouracil

Supplementary concepts

  • Actinic cheilitis